SEARCH

Current Edition

cancer

Cancer Research UK reveals innovation engine underpinned by £400m portfolio of cutting-edge discovery science

Cancer Research UK, the world’s largest independent funder of cancer research, today (Tuesday 26th), unveiled Cancer Research Horizons, its new and ambitious approach to driving …

Continue Reading →
Bluebird

Bluebird’s CFO resigns as cash woes raise doubts about its future

Dive Brief: Bluebird bio’s chief financial officer Gina Consylman will resign amid growing concerns the company needs to raise additional money to survive more than a …

Continue Reading →
20

SanBio Receives $20 Million Grant From CIRM

CIRM is an agency of the State of California formed to accelerate the progress of regenerative medicine through a highly competitive grant program. Prospective grants …

Continue Reading →
20

NBE Therapeutics Closes a CHF 20 Million Financing by Novo Holdings A/S

NBE Therapeutics AG, a biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) for improved cancer therapy, today announces a CHF 20 million extension of the Series …

Continue Reading →
216

United Therapeutics nabs competing PAH drug with $216M SteadyMed buy

Brief: United Therapeutics announced Monday morning that it will acquire competitor SteadyMed for $4.46 per share in cash upfront and another $2.63 per share in …

Continue Reading →
110

Sparks sells regulatory fast pass to Jazz for $110M

Brief: Spark Therapeutics has sold a priority review voucher (PRV) to Jazz Pharmaceuticals for $110 million, according to a Monday disclosure. While details were scant, …

Continue Reading →